|
BD is a global company with facilities and organizations in virtually every country in the world. The Company is comprised of several core market segments that play a unique role within the healthcare industry.
BD Medical
BD Medical includes medical and diabetes care units that embrace four primary product areas:
Medical Surgical Systems provides innovative products, which have had a profound effect on the performance and welfare of health care professionals. Products include injection syringes and needles, infusion therapy devices, anaesthesia needles, surgical blades, scrubs and critical care devices for hospitals and clinics.
Diabetes Care provides solutions for people with diabetes to better manage their condition. With BD blood glucose monitors, insulin syringes and pen needles, people have significantly decreased the complexity and pain associated with managing diabetes. BD also offers Tensor™ branded elastic bandages and athletic braces and supports.
Pharmaceutical Systems provides pre-fillable injection needles to the pharmaceutical industry, which save medical professionals valuable time and improve their overall level of safety.
Ophthalmic Systems, which are known for their innovation, reliability and precision have become the tools of choice for many Canadian Medical professionals. Products include ophthalmic surgical blades and cannulas used for cataract and other eye surgery procedures.
BD Biosciences
BD Biosciences' research and clinical diagnostic systems are the industry standard for studying and monitoring patients with HIV. Through drug discovery and development, immune function monitoring, and functional genomics, BD Biosciences' has become an invaluable resource to academic and government institutions, biotech and pharma companies, hospitals, reference labs and blood banks.
BD Diagnostics
BD Diagnostics includes Preanalytical Systems and Diagnostic Systems. Both provide systems solutions to clinical laboratories' most pressing problems. This approach enables BD Diagnostics to benefit from its established presence in the laboratory and to leverage the brand equity of its existing lines.
|